Skip to main content

AI-Supported Double Mammogram Reading Improves Detection Rate

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 15, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 14, 2025 -- Artificial intelligence (AI)-supported double-reading mammography is associated with a higher breast cancer detection rate, without affecting the recall rate, compared with standard double reading, according to a study published online Jan. 7 in Nature Medicine.

Nora Eisemann, Ph.D., from the Institute for Social Medicine and Epidemiology at the University of Lübeck in Germany, and colleagues compared the performance of AI-supported double reading to standard reading (without AI) among women aged 50 to 69 years undergoing organized mammography screening at 12 sites in Germany. Radiologists voluntarily chose whether to use the AI system or not. A total of 463,094 women were screened (260,739 with AI support) by 119 radiologists from July 2021 to February 2023.

The researchers found that the breast cancer detection rate for radiologists in the AI-supported screening group was 6.7 per 1,000, which was 17.6 percent higher than the rate of 5.7 per 1,000 achieved in the control group. In the AI group, the recall rate was 37.4 per 1,000, which was lower than and noninferior to that seen in the control group (38.3 per 1,000). The positive predictive value of recall was 17.9 and 14.9 percent in the AI and control groups, respectively; the positive predictive value of biopsy was 64.5 and 59.2 percent, respectively.

"Our findings substantially add to the growing body of evidence suggesting that AI-supported mammography screening is feasible and safe and can reduce workload," the authors write.

Several authors disclosed ties to medical technology companies, including Vara, which funded the study.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections

WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...

AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer

TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...

AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors

TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.